YD Bio Ltd
Ownership
Ownership Structure
Who owns YD Bio Ltd (YDES)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 22.3% of the shares are freely tradable; institutional investors hold 0.3%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Garrett Wealth Advisory Group, LLC | 0.12 | 84,630 | +0.0 | 06/30/2026 |
| Geode Capital Management, LLC | 0.09 | 60,236 | +3.2 | 03/31/2026 |
| Cypress Capital Management, LLC | 0.05 | 33,690 | +9.8 | 06/30/2026 |
| HPM Partners LLC | 0.05 | 32,406 | +0.0 | 03/31/2026 |
| Citadel Advisors Llc | 0.04 | 30,106 | +54.8 | 06/30/2026 |
| UBS Group AG | 0.02 | 11,628 | +61.7 | 03/31/2026 |
| Wolverine Asset Management LLC | 0.01 | 4,886 | +94.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Nasdaq Composite Index | 0.06 | 44,942 | +12.8 | 07/31/2026 |
| Fidelity Nasdaq Composite ETF | 0.03 | 22,857 | +0.0 | 08/31/2026 |
| Arrow Long/Short Alt Fd F | 0.03 | 21,000 | +0.0 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Shen Ethan PhD | CEO | 11,258,331 | 64,172,487 $ | Sep 14, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | Shen Ethan PhD | CEO | Buy | 12,700 | 3.85 | 48,895 |
| Sep 9, 2026 | Shen Ethan PhD | CEO | Buy | 3,100 | 3.93 | 12,183 |
| Sep 4, 2026 | Shen Ethan PhD | CEO | Buy | 18,378 | 3.67 | 67,447 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.